WE ARE FOCUSED ON ADDRESSING
OVERLOOKED NEEDS IN RARE BLOOD DISORDERS
WE ARE FOCUSED ON ADDRESSING OVERLOOKED NEEDS IN RARE BLOOD DISORDERS
Research efforts for rare blood disorders have led to treatment advances over the past several decades. Despite this progress, many patients continue to experience significant challenges and inadequate treatment options. We are committed to expanding the focus of rare blood disorder research to address these needs, starting with von Willebrand disease (VWD).
Research efforts for rare blood disorders have led to treatment advances over the past several decades. Despite this progress, many patients continue to experience significant challenges and inadequate treatment options. We are committed to expanding the focus of rare blood disorder research to address these needs, starting with von Willebrand disease (VWD).
COLLECTIVELY FOCUSED ON ONE MISSION
COLLECTIVELY FOCUSED
ON ONE MISSION
Vega Therapeutics is a part of a constellation of companies led by Star Therapeutics, which focuses on developing life-changing therapies for patients with rare diseases.
Vega Therapeutics is a part of a constellation of companies led by Star Therapeutics, which focuses on developing life-changing therapies for patients with rare diseases.